1077 related articles for article (PubMed ID: 6692407)
1. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
[TBL] [Abstract][Full Text] [Related]
2. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology.
Babu VR; Lutz MD; Miles BJ; Farah RN; Weiss L; Van Dyke DL
Cancer Res; 1987 Dec; 47(24 Pt 1):6800-5. PubMed ID: 3479251
[TBL] [Abstract][Full Text] [Related]
3. Karyotypic characterization of urinary bladder transitional cell carcinomas.
Fadl-Elmula I; Gorunova L; Mandahl N; Elfving P; Lundgren R; Mitelman F; Heim S
Genes Chromosomes Cancer; 2000 Nov; 29(3):256-65. PubMed ID: 10992300
[TBL] [Abstract][Full Text] [Related]
4. Recurrent cytogenetic aberrations in human ovarian carcinomas.
Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic features of human neuroblastomas and cell lines.
Brodeur GM; Green AA; Hayes FA; Williams KJ; Williams DL; Tsiatis AA
Cancer Res; 1981 Nov; 41(11 Pt 1):4678-86. PubMed ID: 6171342
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma.
Yoshida MA; Ohyashiki K; Ochi H; Gibas Z; Pontes JE; Prout GR; Huben R; Sandberg AA
Cancer Res; 1986 Apr; 46(4 Pt 2):2139-47. PubMed ID: 3948185
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding.
Fadl-Elmula I; Gorunova L; Mandahl N; Elfving P; Lundgren R; Mitelman F; Heim S
Br J Cancer; 1999 Sep; 81(1):6-12. PubMed ID: 10487605
[TBL] [Abstract][Full Text] [Related]
8. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma.
Höglund M; Säll T; Heim S; Mitelman F; Mandahl N; Fadl-Elmula I
Cancer Res; 2001 Nov; 61(22):8241-6. PubMed ID: 11719456
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
Khaled HM; Aly MS; Mokhtar N
Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
[TBL] [Abstract][Full Text] [Related]
10. Chromosome abnormalities in tumor cells from patients with sporadic Wilms' tumor.
Kondo K; Chilcote RR; Maurer HS; Rowley JD
Cancer Res; 1984 Nov; 44(11):5376-81. PubMed ID: 6091875
[TBL] [Abstract][Full Text] [Related]
11. Fifty-three month persistence of ring chromosome in noninvasive bladder carcinoma.
Falor WH; Ward RM
Acta Cytol; 1976; 20(3):272-5. PubMed ID: 1064279
[TBL] [Abstract][Full Text] [Related]
12. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.
Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C
Int J Cancer; 2001 Jun; 92(6):824-31. PubMed ID: 11351302
[TBL] [Abstract][Full Text] [Related]
13. Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridization.
Stamouli MI; Panani AD; Ferti AD; Petraki C; Oliver RT; Raptis SA; Young BD
Cancer Genet Cytogenet; 2004 Mar; 149(2):107-13. PubMed ID: 15036885
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal analysis of bladder cancer. III. Nonrandom alterations.
Smeets W; Pauwels R; Laarakkers L; Debruyne F; Geraedts J
Cancer Genet Cytogenet; 1987 Nov; 29(1):29-41. PubMed ID: 3311350
[TBL] [Abstract][Full Text] [Related]
15. Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe.
Poddighe PJ; Ramaekers FC; Smeets AW; Vooijs GP; Hopman AH
Cancer Res; 1992 Sep; 52(18):4929-34. PubMed ID: 1516049
[TBL] [Abstract][Full Text] [Related]
16. Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder.
Gronau S; Menz CK; Melzner I; Hautmann R; Möller P; Barth TF
Virchows Arch; 2002 Apr; 440(4):436-40. PubMed ID: 11956826
[TBL] [Abstract][Full Text] [Related]
17. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
18. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
[TBL] [Abstract][Full Text] [Related]
19. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
Panani AD; Ferti AD; Raptis SA; Roussos C
Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
[TBL] [Abstract][Full Text] [Related]
20. [Chromosomal analysis of primary superficial tumors of the bladder].
Martorana G; Giberti C; de Ferrari M; Ottaggio L; Giuliani L
J Urol (Paris); 1983; 89(7):489-92. PubMed ID: 6655279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
